Twist Bioscience Delivers Steep Loss in Fiscal Q2 2019

The DNA synthesis leader is pouring money into R&D and hoping it finds a sustainable business model. That's riskier than investors might realize."Twist Bioscience Delivers Steep Loss in Fiscal Q2 2019" via FOX BIZ https://fxn.ws/2LjJxaR